www.fdanews.com/articles/158612-bristol-myers-squibb-reports-results-for-phase-iii-trial-of-yervoy-in-previously-treated-castration-resistant-prostate-cancer

Bristol-Myers Squibb Reports Results for Phase III Trial of Yervoy in Previously-Treated Castration-Resistant Prostate Cancer

September 12, 2013

Bristol-Myers Squibb’s Yervoy did not meet statistical significance criteria in a Phase III trial comparing prostate cancer patients on the drug with those on docetaxel.
The Herald Online